Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex.
about
Designing Dendrimer and Miktoarm Polymer Based Multi-Tasking Nanocarriers for Efficient Medical TherapyTweaking dendrimers and dendritic nanoparticles for controlled nano-bio interactions: potential nanocarriers for improved cancer targetingDendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issuesMechanisms and implications of dual-acting methotrexate in folate-targeted nanotherapeutic deliveryMultivalent polymers for drug delivery and imaging: the challenges of conjugationRecent advances in dendrimer-based nanovectors for tumor-targeted drug and gene deliveryPolymeric nanoparticles for targeted treatment in oncology: current insightsControlled Drug Release from Pharmaceutical NanocarriersPhysical energy for drug delivery; poration, concentration and activation.Cationic PAMAM dendrimers disrupt key platelet functions.Acyclic CB[n]-type molecular containers: effect of solubilizing group on their function as solubilizing excipients.Polyamidoamine (PAMAM) dendrimer conjugate specifically activates the A3 adenosine receptor to improve post-ischemic/reperfusion function in isolated mouse hearts.Targeted gadolinium-loaded dendrimer nanoparticles for tumor-specific magnetic resonance contrast enhancement.Cooperative nanomaterial system to sensitize, target, and treat tumors.Temperature-sensitive magnetic drug carriers for concurrent gemcitabine chemohyperthermia.Avidity mechanism of dendrimer-folic acid conjugates.Stabilization of the nitric oxide (NO) prodrugs and anticancer leads, PABA/NO and Double JS-K, through incorporation into PEG-protected nanoparticlesCharge-reversal polyamidoamine dendrimer for cascade nuclear drug delivery.Peptide and glycopeptide dendrimers and analogous dendrimeric structures and their biomedical applications.Targeted cellular uptake and siRNA silencing by quantum-dot nanoparticles coated with β-cyclodextrin coupled to amino acids.Clusters of ligands on dendrimer surfaces.Cancer targeted therapeutics: From molecules to drug delivery vehicles.Encapsulation of pyrene-functionalized poly(benzyl ether) dendrons into a water-soluble organometallic cage.Enabling individualized therapy through nanotechnologyInfluence of dendrimer surface charge on the bioactivity of 2-methoxyestradiol complexed with dendrimers.Peptide and glycopeptide dendrimer apple trees as enzyme models and for biomedical applications.Dendrimers in medical nanotechnologyLuminescence targeting and imaging using a nanoscale generation 3 dendrimer in an in vivo colorectal metastatic rat model.Functional block copolymer nanoparticles: toward the next generation of delivery vehicles.Maleimide Functionalized Poly(ε-caprolactone)-b-poly(ethylene glycol) (PCL-PEG-MAL): Synthesis, Nanoparticle Formation, and Thiol Conjugation.Multifunctional drug nanocarriers formed by cRGD-conjugated βCD-PAMAM-PEG for targeted cancer therapyAcyclic cucurbit[n]uril-type molecular containers: influence of glycoluril oligomer length on their function as solubilizing agents.Targeted delivery of polyamidoamine-paclitaxel conjugate functionalized with anti-human epidermal growth factor receptor 2 trastuzumabPolymeric-based particulate systems for delivery of therapeutic proteins.Comparison of two kinds of nanomedicine for targeted gene therapy: premodified or postmodified gene delivery systems.Thermosensitive hydrogel containing dexamethasone micelles for preventing postsurgical adhesion in a repeated-injury model.Particle-based technologies for osteoarthritis detection and therapy.Utilization of H-bond interaction of nucleobase Uralic with antitumor methotrexate to design drug carrier with ultrahigh loading efficiency and pH-responsive drug releaseNitric oxide-releasing dendrimers as antibacterial agents.Utilizing the folate receptor for active targeting of cancer nanotherapeutics
P2860
Q26782404-25C31F28-C1D2-452D-A580-ACF958D5705FQ26785347-1014996C-27BD-4F47-8D40-4F95E186AC5CQ26825175-8E713C2B-1D32-42A4-8714-EF24E20FA875Q26852723-DD0CCC27-901D-4E76-94B2-6D65A0C1005BQ27692689-978CF7F4-7412-4B9E-A81E-7F9F17BCFEA6Q28085438-808E0592-DB3F-4FD4-94C8-FEF6A35B94C9Q28087243-53965B7C-439F-4443-9B44-D8B79E7C49C3Q28257050-230761F2-1B1D-4D21-81B7-B1CEE2FED925Q30412855-6ED2E9D7-A9DA-42E5-B7AA-C2876134D40DQ30514562-5661E4CC-96A4-4123-A776-222A8AB8DFEFQ30770195-D4AC09FB-ECC5-40B3-85A5-731853B28582Q31039936-79813958-B136-4A8C-83DE-29D0370A29FAQ31169933-4F970895-E8BE-480F-8D07-6566D38B677DQ33524689-7865AE2B-68D3-4840-88F8-7B02DB6CB560Q33561078-1F85483D-D65E-4440-9524-D29CFC9C71FBQ33598717-F882E535-DF13-4C1F-B989-79B6D7D853DFQ33624748-E0365EA7-34FD-4ED4-863D-CCF526A435C4Q33734954-B36E84A0-8824-4C71-AA9D-1745F6C22C4CQ33740696-EA4C3196-FA76-44CF-9A9C-98BE1D68D97CQ33862942-10445A3C-2ED3-4AA0-81D8-7C9955B2A03DQ33882982-50B46084-2ABE-4230-B423-679EA8B9BC25Q33887986-A580AF40-1700-4CFF-8B61-8A82308C4781Q33917124-90F9BC33-E231-4A94-9500-6C06C34BD885Q33917755-D9BFB7A3-EA4C-4AB5-9623-1F1293ADF981Q34135619-09B0BD0B-A6D2-435A-9A11-DA913657FC0FQ34139493-FA57C3A6-9EE0-48B3-9CD8-1D23E6583F15Q34369684-FC0C4E4B-0C72-4519-82CB-3694AE7B14DEQ34539866-3F0245AE-6E22-48CC-8226-74F5079565FAQ34641749-1A670096-4F08-416A-AC0B-DBE05DCC300DQ35083235-DB6756F1-131F-401C-8340-53CBD6C9661EQ35108257-2712EF36-487B-4CE9-BFEB-A06F4FD955EBQ35196330-0C2A102F-F2EA-4BBE-AC32-856C424E9D8EQ35209810-DBD7C9F7-1F8B-497B-AE4C-5BC8D2EBF368Q35539532-9CD48F0B-EC7F-4A8D-8EE9-2D8C25F9E276Q35972662-C6266B03-81D2-44FE-9CAD-24C588D62A72Q36012282-C8BE7C60-8CF6-4494-8EBA-05118683C823Q36303687-A6E82976-5675-459D-BC1F-6AC50097EB06Q36345098-6D8FA6C2-7887-4C28-954D-264C64B77F57Q36352418-AB46E306-6103-464F-80D2-D12A09B8A68EQ36463444-E734045A-AE51-4A78-818B-29BAFD6E5843
P2860
Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Targeted drug delivery with de ...... valent drug inclusion complex.
@ast
Targeted drug delivery with de ...... valent drug inclusion complex.
@en
Targeted drug delivery with de ...... valent drug inclusion complex.
@nl
type
label
Targeted drug delivery with de ...... valent drug inclusion complex.
@ast
Targeted drug delivery with de ...... valent drug inclusion complex.
@en
Targeted drug delivery with de ...... valent drug inclusion complex.
@nl
prefLabel
Targeted drug delivery with de ...... valent drug inclusion complex.
@ast
Targeted drug delivery with de ...... valent drug inclusion complex.
@en
Targeted drug delivery with de ...... valent drug inclusion complex.
@nl
P2093
P1476
Targeted drug delivery with de ...... valent drug inclusion complex.
@en
P2093
Anil K Patri
James R Baker
Jolanta F Kukowska-Latallo
P304
P356
10.1016/J.ADDR.2005.09.014
P407
P577
2005-11-14T00:00:00Z